Insmed Stock Market Sentiment

INSM Stock  USD 19.54  0.30  1.56%   
Insmed's investor sentiment overview provides quick insight into current market opportunities from investing in Insmed Inc. The current market sentiment, together with Insmed's historical and current headlines, can help investors time the market. In addition, many technical investors use Insmed Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Check out Insmed Hype Analysis, Insmed Correlation and Insmed Performance.
  
Insmed stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Insmed daily returns and investor perception about the current price of Insmed Inc as well as its diversification or hedging effects on your existing portfolios.

Insmed Historical Sentiment

Although Insmed's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Insmed, such as negative comments on social media and news outlets, may cause fear in the market and push Insmed's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Insmed.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Insmed's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Insmed Inc.

Insmed Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Insmed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Insmed Inc Historical Investor Sentiment

Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Insmed news discussions. The higher the estimate score, the more favorable the investor's outlook on Insmed.
over a week ago at thelincolnianonline.com         
Insmed Cut to Sell at StockNews.com
news
over a week ago at www.macroaxis.com         
Sale by John Wise of 3366 shares of Insmed
Macroaxis News
over a week ago at news.google.com         
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conferen...
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conferen...
Yahoo News
over a week ago at simplywall.st         
Melvin Sharoky Bought 6.6 percent More Shares In Insmed
Simply Wall St News at Macroaxis
over two weeks ago at gurufocus.com         
This Insider Just Sold Shares of Insmed Inc
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Insider Alert An Insider Just Sold Insmed Inc Shares
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Sale by John Wise of 593 shares of Insmed
Macroaxis News
over two weeks ago at www.macroaxis.com         
Acquisition by John Wise of 31662 shares of Insmed subject to Rule 16b-3
Macroaxis News
over three weeks ago at insidermonkey.com         
Insmed Incorporated Q1 2023 Earnings Call Transcript
insidermonkey News
over three weeks ago at finance.yahoo.com         
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, The Future of ...
Yahoo News
over three weeks ago at finance.yahoo.com         
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635
Yahoo News
over three weeks ago at simplywall.st         
Insmed First Quarter 2023 Earnings Revenues Beat Expectations, EPS Lags
Simply Wall St News at Macroaxis
over a month ago at investing.com         
Insmed earnings missed by 0.04, revenue topped estimates
Investing News at Macroaxis
over a month ago at zacks.com         
Revance Therapeutics, Inc. Expected to Beat Earnings Estimates What to Know Ahead of Q1 Release
zacks News
Far too much social signal, news, headlines, and media speculation about Insmed that are available to investors today. That information is available publicly through Insmed media outlets and privately through word of mouth or via Insmed internal channels. However, regardless of the origin, that massive amount of Insmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insmed alpha.

Insmed Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
Check out Insmed Hype Analysis, Insmed Correlation and Insmed Performance. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.39) 
Revenue Per Share
2.021
Quarterly Revenue Growth
0.228
Return On Assets
(0.25) 
Return On Equity
(14.53) 
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.